$66.28
0.570.87%
가까이에: Sep 23, 5:00 PM EST
$66.51
0.801.22%
프리마켓: 7:13 AM EST
Benzinga
Benzinga
Benzinga
금요일, 9월 25
BridgeBio Pharma Inc
BBIONASDAQ
BridgeBio Pharma Earnings & Forecasts
BridgeBio Pharma (BBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
BridgeBio Pharma Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.59 | $-0.63 | $-0.67 | $-0.82 |
| Actual | $-0.78 | $-0.84 | $-1.00 | $-0.95 |
| Surprise | -32.2% | -33.3% | -49.3% | -15.8% |
| Revenue | ||||
| Estimate | $220.3M | $178.8M | $149.5M | $105.8M |
| Actual | $243.7M | $194.5M | $154.2M | $120.7M |
| Surprise | +10.6% | +8.76% | +3.16% | +14.1% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.64 | $-0.44 | $-0.45 | $-0.22 |
| Revenue | ||||
| Consensus | $270.0M | $318.3M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved